Objectives. Non-radiographic axial SpA (nr-axSpA) comprises those patients who may have clinical and laboratory features of SpA but do not have definite radiographic sacroiliitis. Bone loss (osteopenia or osteoporosis) is well recognized in AS, however, bone status in nr-axSpA is unclear. The aims of this study were to investigate BMD in patients with nr-axSpA and compare them with age-and sex-matched patients with mechanical low back pain (mLBP). The relationship between inflammation on MRI of the lumbar spine and BMD was also assessed in nr-axSpA.
Introduction
SpA is a group of inflammatory arthritides and an association with HLA-B27 and involvement of the axial skeleton are important hallmarks of the disease [1, 2] . Axial SpA has been used to describe SpA that has predominant axial involvement, irrespective of the presence of structural damage on plain radiographs. The newly developed Assessment of SpondyloArthritis International Society (ASAS) classification criteria proposes to classify SpA according to leading clinical manifestations: predominantly axial or predominantly peripheral and with or without associated psoriasis, inflammatory bowel disease or preceding infection [3] . Non-radiographic axial SpA (nraxSpA) comprises those patients who may have clinical and laboratory features of SpA but do not have definite radiographic sacroiliitis and may have early MRI features on the sacroiliac joints [4] . A substantial proportion of the patients with SpA and nr-axSpA may develop AS over time. In a Brazilian cohort of patients with undifferentiated SpA, 24.3% developed AS over 510 years of follow-up [5] , and in a German cohort of patients with nr-axSpA only 11.6% developed AS over 2 years of follow-up [6] .
Low bone mass (osteopenia or osteoporosis) is a wellrecognized complication of AS [7, 8] and osteoporotic vertebral fractures may occur [9] . BMD may be effected in the early stages of the disease [10] and two longitudinal studies in early AS have shown that spine and hip BMD decreased predominantly in patients with active disease [11, 12] . In the current literature, bone mass has been evaluated largely in established AS, which represents patients with definite radiographic sacroiliitis corresponding to a symptom duration of at least 5 years. However, little is known about the bone mass in patients with early SpA and, to the best of our knowledge, no study is available comparing bone mass in patients with nr-axSpA with those with mechanical low back pain (mLBP). Therefore the aim of this study was to investigate BMD in patients with nr-axSpA and compare them with age-and sex-matched patients with mLBP as controls. Also, we aimed to investigate the relationship between disease activity, functional ability, quality of life, presence of acute inflammation on lumbar MRI and vitamin D status in patients with nr-axSpA who were in the very early stage of the disease.
Materials and methods
Patients with chronic LBP were consecutively recruited from our rheumatology outpatient clinic and the inclusion criteria were as follows: age between 18 and 45 years and a history of chronic (lasting more than 3 months) LBP no more than 3 years. The exclusion criteria were spinal surgery or other spinal disorders that were clearly defined, under treatment with systemic corticosteroids or biologic agents, known diagnosis or receiving treatment for osteoporosis or osteomalacia and other neuroendocrine and orthopaedic disorders that may interfere with bone metabolism. The study was approved by the Ethical Committee of Firat University and all participants provided informed consent. Diagnosis of axial SpA was made upon consensus of two experienced rheumatologists and then patients were assessed for fulfilment of ASAS axial SpA criteria [3] . Chronic LBP patients without any evidence of axial SpA and diagnosed with mLBP upon consensus of two rheumatologists were included as the control group.
All of the patients underwent lumbar and pelvic X-ray examination and the presence of radiographic sacroiliitis was assessed by two experienced rheumatologists. Patients with evidence of definite sacroiliitis on pelvic X-rays (upon consensus of rheumatologists) were excluded. The rest of the patients underwent sacroiliac and lumbar MRI on a 1.5-T MR scanner (Signa Excite, GE Healthcare, Milwaukee, WI, USA) using our previously defined imaging protocol [13, 14] . One experienced rheumatologist (S.O.) examined the spinal and sacroiliac images and judged the presence of sacroiliitis and classified lumbar spinal scans (L1L4) as the presence or absence of bone oedema (BO, yes/no) at the vertebral corpus or endplates according to the recommendations of the ASAS/OMERACT MRI study group [15] .
BMD was measured at the lumbar spine and proximal femur using DXA on a Hologic QDR Discovery Wi (S/N 84440) (Hologic, Bedford, MA, USA). Dual energy X-ray measurements were expressed as BMD (in g/cm 2 ), Z and T scores, which corresponds to the scores in the reference population as supplied by the manufacturer (Hologic). The short-term precision for spinal and hip measurements had a coefficient of variation of 13%. All of the participants were assessed for demographic variables as well as clinical symptoms and features. Duration of symptoms was defined as the time elapsed from the onset of the first symptoms related to the axial skeleton. Clinical features of SpA were assessed and anthropometric measurements were performed, including the BASMI as well as BASDAI (010), AS DAS (ASDAS-CRP) and BASFI (0100).
Biological variables assessed in the study included complete blood count, ESR (in mm/h), CRP (in mg/dl, normal limits 06 mg/dl) and HLA-B27 antigen. Also, blood chemistry, including serum levels of 25(OH)D 3 , calcium, phosphorus, ALP, parathyroid hormone and thyroid hormones were assessed. Vitamin D levels were measured using HPLC between November and February and hormone levels were measured using a chemiluminescent immunoassay system.
Statistical analysis was performed using SPSS, version 15.0 (IBM, Armonk, NY, USA) software. Data were expressed as the mean (S.D.). The normality of distribution was analysed by the KolmogorovSmirnov test and the 2 Â 2 contingency tables were formed for categorical variables and analysed by chi-square or Fisher's exact test. The statistical significance of the mean difference between patients with nr-axSpA and mLBP was examined using the t-test for normally distributed variables and MannWhitney U-test for skewed variables. A P-value of 0.05 was considered statistically significant.
Results
Forty-six patients who met criteria for nr-axSpA and 29 patients with mLBP were included. Demographic and clinical variables are shown on Table 1 . HLA-B27 was positive in 28 patients (60.8%) with nr-axSpA and 2 (6.9%) with mLBP. Patients with nr-axSpA had a slightly higher BMI compared with patients with mLBP (P = 0.009). All of the women in both groups were premenopausal. Some of the variables that may potentially interfere with bone mass, such as tobacco use and the number of gestations and number of deliveries in women, were similar between groups. None of the patients in either group had a history of osteoporotic vertebral or non-vertebral fracture.
Regarding the anthropometric measurements, significant difference appeared only in Schober's test (P < 0.0001) and chest expansion (P = 0.035), which were restricted in the nraxSpA group. Patients with nr-axSpA had poorer BASFI (P < 0.0001) and higher BASDAI (P < 0.0001) scores and slightly lower haemoglobin [mean 14.45 (S.D. 1.37) vs 15.18 (1.37) g/dl, P = 0.028] and slightly higher phosphorus [mean 3.34 (S.D. 0.43) vs 3.11 (0.42) mg/dl, P = 0.028] levels compared with patients with mLBP. BMD values and T and Z scores at L1L4 and L2L4 were lower in nr-axSpA compared with patients with mLBP, whereas BMD, T and Z scores were similar at the proximal femur. 25(OH)D 3 levels as well as parathyroid hormone and thyroid function tests were similar between groups (Table 1) .
Twenty (43.5%, 16 male) patients had BO on lumbar spinal MRI representing acute inflammation, whereas 26 (56.5%, 16 male) patients did not have BO. Supplementary Fig. S1 , available at Rheumatology Online shows inflammation on a lumbar MRI of a patient (see supplementary Fig. S1 , available at Rheumatology Online). These subgroups were gender matched (chi-square P = 0.117). Comparison of BMD, T and Z scores in the nr-axSpA subgroups revealed that patients with inflammation had lower BMD and worse T and Z scores at the lumbar spine and hip (Table 2) .
Discussion
This study revealed that patients with axial SpA have lower bone mass compared with age-and sex-matched patients with mLBP. Also nr-axSpA patients with inflammatory lesions on spinal MRI had lower BMD at the spine and hip, indicating inflammation has a negative effect on bone mass.
Tremendous progress has been made in the treatment of axial SpA over the past decade; NSAIDs have been generally accepted as the first-line treatment in axial SpA, including the nr-axSpA. TNF blockers have proven efficacy in patients with nr-axSpA, who responded similarly well to these treatments compared with patients with 
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Bone mass in non-radiographic axial SpA established AS [16] . Bone loss, which is associated with spinal inflammation, may be prevented in the very early stages of the disease with these potent TNF blocking agents whose efficacy has been previously shown in AS [17] . Previous studies have shown low BMD, particularly in patients with early and active AS [7, 11] . Our results confirm the findings of recent research assessing bone mass in patients with very early inflammatory back pain (IBP) and undifferentiated SpA [18, 19] . In the first study, patients with IBP (25/30 met the ASAS criteria for axial SpA) have been followed for 1 year for changes in DXA measurements [18] . An association between higher CRP levels with bone loss at the hip and spine was found. However, there was an association of BO on the sacroiliac MRI, with bone loss at the femoral neck only. Interestingly, the association between inflammation and bone loss appeared in the femur and spine, but not the hand, indicating the site-specific relationship between bone loss and inflammation [18] .
Another study presented the results of a large cohort of patients with early IBP (DESIR cohort) [19] . In this study 332 patients with IBP, suggestive of axial SpA, were evaluated for the possible parameters associated with low bone mass at the spine and hip. The significantly associated parameters with low BMD were bone marrow oedema (BMO) on MRI, acute phase response (ESR or CRP) and male gender. This study clearly demonstrated the association of low BMD with inflammation (BMO on MRI or biologic markers of inflammation).
The causal relationship of inflammation and bone density may be extracted from the results of other studies. Inflammatory lesions resolve after anti-TNF treatments in patients with axial SpA [20] , and a significant increase in bone mass in patients with SpA who received anti-TNF treatments for 2 years has been documented [17] . Taken together, a causal relationship between inflammation and bone loss may be suggested in patients with SpA.
In our study we showed that patients with nr-axSpA have lower spinal BMD compared with matched controls with mLBP. One of the major limitations of DXA measurements in patients with AS (particularly in established cases) is the artefactual increase of spinal BMD values related to the syndesmophytes or increased bone formation [8] . However, this is less problematic in early cases without definite radiographic changes in the spine.
Our study has some limitations. First, the study population was relatively small compared with similar studies assessing osteoporosis or low bone mass in target populations. Second, in the nr-axSpA group, the exact proportion of patients who will further progress to AS is not known, therefore our results should be confirmed with longitudinal data that will follow the patients for further radiographic progression. In conclusion, our results showed that patients with nr-axSpA had lower bone mass compared with mLBP patients, and low bone mass is associated with ongoing spinal inflammation on MRI. 
Rheumatology key messages
. Non-radiographic axial SpA (nr-axSpA) patients had significant bone loss in the lumbar spine compared with patients with mechanical low back pain. . Low bone mass is associated with ongoing spinal inflammation on MRI in patients with nr-axSpA.
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